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ABSTRACT 
STRUCTURE-ACTIVITY RELATIONSHIP MODEL FOR ESTROGEN 
RECEPTOR LIGANDS 
Huihui Wu 
November 29,2011 
Xenoestrogens are spread throughout the environment affecting our daily 
lives and may produce potential toxic effects on human health. The purpose of 
this study was to develop a mechanistically reliable model capable of identifying 
xenoestrogens. Our hypothesis was that there are identifiable structural 
characteristics among a diverse set of estrogen receptor ligands that differentiate 
estrogenic and nonestrogenic compounds. The model's learning set was 
developed by collecting compounds from the National Center for Toxicological 
Research Estrogen Receptor Binding database (NCTRER) . The 
categorical-SAR (cat-SAR) expert system was used to build the models and 
perform leave-none-out, leave-one-out, leave-many-out and external validations 
for model analysis. The values of all validations were between 0.80 and 0.97. 
Based on several analyses of rational subsets of compounds included in the 
NCTRER based on potency or chemical structure, it was observed that the 
developed SAR models predictivity varied across sets. This indicates that 
variability in the SAR models or the in vitro assay results themselves must be 
considered when applying SAR models for prediction or mechanistic analyses of 
v 
estrogen receptor ligands. Fragment analysis was carried out to study the 
mechanism of estrogen receptor binding, and various important fragments were 
identified that demonstrate potential structural characteristics important for 
binding. Furthermore, this led to the discovery that the cat-SAR expert system 
was able to make a higher percentage of correct predictions on specific classes of 
xenoestrogen expressing these key functional groups. In conclusion, this 
estrogen receptor ligand model has good predictive performance and is based on 
model attributes that are mechanistically sound. 
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CHAPTER I 
INTRODUCTION 
Estrogen is an essential hormone in many biological processes such as 
sexual development, reproduction, cardiovascular and bone health. It is a steroid 
hormone, and includes three naturally occurring types: estrone, 17~-estradiol 
and estriol. 17~-estradiol is the predominant form in non-pregnant females. For 
medical applications, estrogen receptor agonists and antagonists can be used as 
oral contraceptives, hormone replacement therapies, and breast cancer 
therapies. 
Estrogen and its derivatives produce effects though the interaction with the 
estrogen receptor (ER). As of now, three types of ERs have been identified: ER-a, 
ER-~, and G protein-coupled receptor 30 (GPR30) [1-4]. ER-a and ER-~ are 
classic nuclear receptors and act as ligand-activated nuclear transcription factors 
that bind regulatory response elements in the promoter regions of genes [5] and 
regulate gene expression. GPR30 is a seven transmembrane domain G 
protein-coupled receptor (GPCR) with low homology to existing GPCRs [6] It 
binds estrogen and triggers the rapid non-genomic signaling events such as 
mitogen-activated protein kinase (MAPK) and Akt pathway activation [7]. 
Therefore, estrogens can trigger both genomic and non-genomic signaling 
pathways. Also, the ERs are widely distributed throughout the body, and found in 
such systems as the cardiovascular, nervous, reproductive, and musculoskeletal 
[8]. The various types and locations of ERs as well as the multiple effects they 
cause make them critical in human physiology and pathology. 
Recent studies have shown that there are various types of chemicals found in 
the environment that can mimic the action of natural estrogen. These compounds 
are called endocrine disruptors (EDs), and are substances that "interfere with the 
synthesis, secretion, transport, binding, action, or elimination of natural hormones 
in the body that are responsible for development, behavior, fertility, and 
maintenance of homeostasis (normal cell metabolism)" [9]. In 2009 The 
Endocrine Society released a scientific statement outlining mechanisms and 
effects of endocrine disruptors on reproduction, development, breast cancer, 
prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and 
cardiovascular endocrinology. They also used results from experimental and 
epidemiological studies "to implicate EDs as a significant concern to public health" 
[10]. 
EDs can be found in a variety of materials, including drugs, plant constituents, 
pesticides, compounds used in the plastics industry, consumer products, and 
other industrial by-products and pollutants [41]. Some are pervasive and widely 
dispersed in the environment. Some are persistent organic pollutants (POP), and 
can be transported long distances across national boundaries [11]. Food is a 
major route by which people are exposed to EDs. Diet is thought to account for up 
to 90% of a person's polychlorinated biphenyls (PCB) and 
dichlorodiphenyltrichloroethane (DDT) body burden [10]. With the increase in 
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household products containing EDs, indoor air has also become a significant 
source of exposure [12]. 
Xenoestrogens, a subset of EDs, are a diverse group of chemicals that bind 
to the ER, mimic natural estrogen action, and interfere with normal endocrine 
system function. Xenoestrogens, which can be produced naturally (e.g. 
phytoestrogen) or synthetically (e. g. bisphenol A (BPA), DDT, etc.), are currently 
the most studied EDs due to their various potential effects on human health. 
Humans are exposed to xenoestrogens in their everyday life, from the food they 
eat to the products they use, and their potential effects are very complicated. 
Some xenoestrogens have been implicated in a variety of environmental health 
problems, in both males and females, including disrupting the normal secretion of 
hormones and disturbing the body's metabolism, which can have serious 
consequences, including damage to reproductive functions [13]. DDT has been 
reported to induce the feminization of gull embryos [14]. Another important 
potential effect of some xenoestrogens is carcinogenesis, specifically in relation to 
breast cancer. These xenoestrogens can mimic 17J3-estradiol by binding the ER 
causing alterations to normal gene transcription and expression of ER and may 
lead to the occurrence of breast cancer [15]. There is substantial evidence in a 
variety of recent studies to indicate that estrogenic chemicals can increase breast 
cancer cell line growth in tissue culture [16]. In clinical practice, hormone 
replacement therapies have been related to increased cases of breast cancer 
[17]. 
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In spite of the harmful effects, xenoestrogens also have been associated with 
benefiting human health. For example soybean products, which are rich in 
phytoestrogens including coumestrol, are common in the daily diets of East 
Asians and are believed to be the reason that the incidence of breast cancer in 
East Asian women is much lower than western women [18]. 
As far as the complicated potential effects of xenoestrogens, a better 
understanding of xenoestrogens, their identification, and mechanisms of action is 
of great significance. The United States Environmental Protection Agency (EPA) 
has initiated a screening and testing strategy to determine whether exogenous 
substances may have an effect in humans similar to those of natural hormones. 
Eighty seven thousand chemicals were quoted by the EPA as potentially requiring 
analysis for endocrine activity [19]. 
Traditional methods for estrogen determination are bioassays, such as the 
competitive receptor binding assay, E-screen assay or uterotrophic assay. The 
E-screen assay was developed to assess the estrogenicity of environmental 
chemicals using the proliferative effect of estrogens on their target cells (MCF-7) 
as an end point [39]. The uterotrophic assay is an in vivo assay for estrogenicity. It 
is based on the principle that the growth phase of the uterus in the natural estrous 
cycle is under the control of estrogen [40]. However, concern about the amount of 
chemicals needed for the test, prohibits the timely and costly route of bioassay 
analysis. Therefore, alternative approaches, such as structure activity relationship 
(SAR) modeling, may overcome these problems and make it possible to screen a 
large number of chemicals in a reasonable time. 
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SAR is a methodology to study the relationship between the chemical 
structure of a molecule and its biological activity. The analysis by SAR may 
identify the chemical groups responsible for producing a biological effect in an 
organism. Therefore, SAR has become a powerful tool for screening and 
mechanism of action analysis. SAR models can be built using chemicals with 
similar or diverse structures that demonstrate similar toxic effects, which can then 
be used as screening tools for compounds with unknown activities. Furthermore, 
it may be possible to modify a compound's structure to determine which 
substructure is associated with a specific biological activity. Medicinal chemists 
use the techniques of chemical synthesis to insert new chemical groups into a 
biomedical compound and test the biological effects of the modifications. 
In comparison to bioassay studies, SAR modeling may be an efficient way to 
screen xenoestrogens. Thousands of chemicals can be screened per day, making 
it a very important alternative and complimentary technique for xenoestrogen 
screening. By using SAR modeling, some structural alerts related to estrogenic 
ligand binding have been discovered. However, this information is not complete 
because the current structural alerts cannot explain the potency or the activity (i.e., 
from ER binding to high level health effects) of all the xenoestrogens. For example, 
the aromatic ring is considered an important structural alert for estrogenicity. 
However, not all aromatic compounds are estrogenic, including flavone and 
catechin. Furthermore, aromatic estrogenic compounds have a wide range of 
affinities for the ER. Some of these compounds are strong binders (17~-estradiol), 
while others are weak binders (BPA). Therefore, aromaticity alone cannot explain 
5 
the activity of xenoestrogens. This project will use SAR modeling to build models 
to screen xenoestrogens with regard to their potency and study the mechanisms 
for receptor binding. We will also model several common subclasses of ER 
mimics, such as biphenyl, steroid and phytoestrogen, to investigate the effect of 
classes on predictivity. By doing so, we hope to get a better understanding of the 
roles that the existing structural alerts play. 
Some SAR models for the estrogen receptor ligands have been developed, 
including qualitative and quantitative ((0) SAR) models. For example, the Multiple 
Computer Automated Statistical Evaluation Expert System (MultiCASE) is a 
semi-quantitative model, and has been recently employed for screening 
chemicals with ER binding potential [20]. Gilles et a/. used the MultiCASE expert 
system to do the SAR study on a diverse set of ER ligands. In their study, 
substructural features associated with ER binding activity and features that 
prevent receptor binding were identified [20]. The fundamental assumption of 
MultiCASE is that the observed biological activity of a molecule is governed by 
substructures called biophores. However, there are certain disadvantages of 
using MultiCASE. For example, the false positives are not correctable, and 
predictions may not be defensible and mayor may not reflect known mechanisms. 
This is because MutiCASE is a black box system, and people cannot get into the 
inside of a model to see the process of its predictions. For OSAR models, the 
Comparative Molecular Field AnalysiS (CoMFA) is a widely used 3D OSAR 
method in drug design, and has been widely used to develop models correlating 
structural differences in molecules with their ability to compete for binding to the 
6 
ER [21]. Wu et al. carried out a study on 3D QSAR of f1avonoids and ER based on 
docking. In this study, they identified the structural features associated with 
estrogenic activity by providing insight into the interaction between the ligands 
and key amino acid residues in the binding pocket [43]. The basic assumption in 
CoMFA is that a suitable sampling of static (van der Waals) and electrostatic fields 
around a set of aligned molecules yields information necessary to explain their 
biological activities. The disadvantage of CoMFA is that it requires structurally 
similar compounds and their accurate alignment. In summary, previous 
xenoestrogen models lacked transparency, were not mechanistically sound, or 
could not be used with a diverse groups of chemicals. The goal of this study is to 
eliminate these deficiencies. 
For this study, we used the cat-SAR expert system. The cat-SAR expert 
system tries to compensate for some limitations of the existing modeling systems. 
It is a computationally based SAR expert system that was originally developed to 
associate 20 chemical fragments with active and inactive compounds in a 
learning set. Unlike other 20 approaches including MultiCASE, cat-SAR is 
transparent and does not include proprietary code. The approach is sharable and 
allows unrestricted scrutiny, intervention, and optimization throughout the 
modeling process. Unlike CoMFA, cat-SAR also does not require a congeneric set 
of molecules, which makes it more applicable for diverse sets of compounds. The 
previous studies on the MCF-7 cell proliferation model [22] and rat carcinogenesis 
model [37] with cat-SAR produced validated results which demonstrate that 
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cat-SAR is a reliable modeling method for identifying structural attributes 
associated with xenoestrogens. 
SAR modeling can also contribute to breast cancer prevention and therapy. 
Currently, effective therapies exist to treat breast cancer, but there is a lack of 
effective chemopreventative agents. SAR models can act as a screening tool to 
differentiate the beneficial and harmful effects related to xenoestrogens. Modeling 
of xenoestrogens may reduce breast cancer risks by allowing for quick 
identification and understanding of their mechanisms of action. Therefore, SAR 
can play a role in breast cancer prevention by either reducing the exposure of 
carcinogenic xenoestrogens or broadening the use of anti-cancer xenoestrogens. 
For breast cancer therapy, SAR may be helpful to facilitate the development of 
novel anti-breast cancer medications by maximizing the drug's specific action on 
the breast tissue but minimizing the toxic effect on other organ sites. 
In this thesis, the cat-SAR expert system was used to model the NCTRER 
database. Cat-SAR models for ER binding will be built based on this database. 
The effects of ligand potency and chemical structure will be studied. 
Xenoestrogen will be divided into several groups according to their relative 
binding affinity (RBA) value and chemical classes, such as biphenyls, 
diphenymethane, phytoestrogen, phenols, DES, and steroids. The relationship 
between model accuracy and RBA value and chemical classes will be analyzed 
based on the cat-SAR models. The model's performance and the structural 
characteristics of these groups will be studied. Moreover, the fragments of 
representative chemicals created by the cat-SAR models will be investigated. 
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The database 
CHAPTER II 
MATERIALS AND METHODS 
The NCTRER data was collected from the in vitro ER competitive-binding 
assay, which provides quantitative assessment of a chemical's ability to bind to 
the ER. The NCTRER database consists of 232 chemicals of which 131 are 
ligands, 93 non-ligands and 8 marginally binding compounds. The compounds 
were selected a priori based on structural characteristics and tested in a well 
validated and standardized in vitro rat uterine cytosol ER competitive-runding 
assay [23, 24]. This assay tested the IC5a of 17~-estradiol and each potential 
ligand. The relative binding affinity (RBA) values were calculated by dividing the 
IC5a of 17~-estradiol by the IC5a of the competitor and multiplying by 100 ( RBA = 
(17~-estradiol IC5a! Competitor IC5a) X 100). IC5a is a measure of the 
effectiveness of a compound in inhibiting biological or biochemical function. This 
quantitative measure indicates how much of a particular drug or other substance 
(inhibitor) is needed to inhibit a given biological process (or component of a 
process, i.e. an enzyme, cell, cell receptor or microorganism) by half. The 
chemicals were divided into ligand or non-ligand by their RBA values. If the RBA 
value is equal to 0, it is considered as non-ligand. If the RBA value is greater than 
1x10-5 , it is considered as ligand. Otherwise it is a marginally binding compound. 
The database is a structurally diverse set of natural, synthetic, and environmental 
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estrogens covering most known estrogenic classes and spanning a wide range of 
biological activity. It represents the largest published ER binding database of 
same-assay results generated in a single laboratory [25]. NCTRER database was 
downloaded from the EPA website. The structures of the 232 chemicals were 
input into the sybylB.1 software [42] for the purpose of fragmentation, visualization 
and record keeping. 
Create activity file 
The activity file is a crucial file in the modeling process because it is needed 
for matrix building and all the validations. After the database was built, an activity 
file was created according to the RBA value reported by the NCTRER database. 
In the activity file, the ligand was defined as "1", and the non-ligand "0", and the 
number "1" and "0" were listed in one column in the same order with the database 
so that it can be input into the database directly. The activity file was saved as 
a .txt file. 
Learning set development 
The cat-SAR models were built through a comparison of structural features 
found amongst two designated categories of compounds in the model's learning 
set: ligand (active) and non-ligand (inactive). The cat-SAR learning set consists of 
the chemical name, its structure as a MOL2 file, and its categorical designation 
(e.g. "1" for ligand and "0" for non-ligand). Typically, organic salts are included as 
the freebase, simple mixtures and technical grade preparations are included as 
the major or ligand component, and metals, metal organic compounds, polymers, 
and mixtures of unknown composition are not included. In our study, we have 
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developed three learning sets: marginal chemicals as ligands (M+), marginal 
chemicals as non-ligands (M-) and marginal chemicals excluded (non-M). 
In silico chemical fragmentation and the compound-fragment matrix 
The Tripos SybylB.1 HQSAR module [26] was used to fragment the 
chemicals in silica into all possible fragments meeting user-specified criteria. In 
HQSAR, the attributes were selected for fragments determination such as atom 
counts (i.e., the size of the fragments), bond types, atomic connections (i.e., the 
arrangement of atoms in the fragment), explicit hydrogen atoms, chirality, and 
hydrogen bond donor and acceptor groups. Fragments can be linear, branched, 
or cyclic moieties. Models developed herein contained fragments between two 
and seven atoms in size and considered atoms, bond types, and atomic 
connections as well as the hydrogen atoms. 
After fragmentation, a compound-fragment data matrix was produced with a 
Sybyl HQSAR addon as a text file. In the matrix, the rows are intact chemicals and 
columns are the molecular fragments. Thus for each chemical, a tabulation of all 
its fragments are recorded across the table rows, and for each fragment all 
chemicals that contain it are tabulated down the columns. The 
compound-fragment matrix is analyzed with the cat-SAR programs to identify 
structural features associated with the categorized ligand and non-ligand 
compounds. 
Identifying important fragments 
A measure of each fragment's association with biological activity was next 
determined. To ascertain an association between each fragment and biological 
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activity, a set of rules are parameterized to choose important ligand and 
non-ligand fragments. The first selection rule is the "number rule" which is the 
number of chemicals in the learning set that contains a fragment. The second rule 
is the "proportion rule" which considers the percentage of ligand or non-ligand 
compounds that possess each fragment. For example 4/0.9/0.85, the number 4 
reflects the "number rule" which means the fragment must be found in at least 4 
compounds. When the number rule is too small, it may risk inclusion of fragments 
that do not relate to certain biological activity because a large amount of 
fragments will be produced. On the other hand, the large value of this number 
would increase the chance of missing important features based on the diverse 
nature of the learning set. The numbers 0.9 and 0.85 are the "proportion rule", and 
this means the fragment should be found in at least 90% of ligands or 85% of 
non-ligands. The values of the "number rule" and "proportion rule" were estimated 
by the cat-SAR Rule Optimization routine. The Rule Optimization routine in our 
study allowed the "number rule" to range between 1 and 8 with increasing 
intervals of 1 and the "proportion rule" to range between 0.50 and 0.95 with 
increasing intervals of 0.05 [27]. We reasoned that even if a particular fragment is 
associated with a ligand, there may yet be other reasons for the compound from 
which it is derived to be classified as a ligand (e.g., other fragments or 
chemicophysical properties), thus it would not be expected to be found in 100% of 
the ligand. Likewise is true for fragments associated with non-ligand. Thus, if we 
considered only those fragments found exclusively in ligand or non-ligand we 
would rarify the fragments pool to an unreasonable level and risk losing valuable 
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information. On the other hand, we expected that fragments found to be 
presented approximately equal in the ligand and non-ligand fragment sets would 
not be associated with biological activity. Such fragments may serve as structural 
scaffolds holding the biologically features and are not directly related to activity or 
inactivity. It should be noted that the cat-SAR program uses a weight-of-evidence 
approach to select important fragments, rather than statistical analysis. 
Predicting Activity 
The resulting list of important fragments can be used to predict the activity of 
an unknown compound (compound that we do not know its activity). The 
approach compares the important fragments between learning sets and those in 
the unknown compound. If they have no common important fragments, no 
prediction of activity is made If there are common important fragments, cat-SAR 
can make a prediction for the compound with uncertain activity according to the 
percentage of activity of the common important fragments. The probability of 
activity or inactivity is then calculated based on the total number of ligand and 
non-ligand compounds containing the fragments. 
To classify an unknown compound back to a ligand or non-ligand category, 
rather than a probability of activity, the program identifies an optimal cut-off point 
that is able to separate ligand from non-ligand based on the model validation 
analysis [28]. The compound predicted with a value larger than the cut-off value is 
considered to be a ligand; otherwise it is considered a non-ligand. The cut-off 
point can be adjusted according to the best overall concordance or the balance of 
sensitivity and specificity. 
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Model validation 
Both internal and external validations were conducted for each model. For 
the internal validation, the leave-none-out (LNO), leave-one-out (LOO), and 
leave-many-out (LMO) validations were used. For the LNO, a model was 
developed from the complete learning set of 232 compounds and the model was 
used to predict the activity of each compound in the learning set. For the LOO 
validation, each chemical, one at a time, was removed from the model's learning 
set. The remaining n-1 compounds were used to build a n-1 model. The activity of 
the removed compound was then predicted by the n-1 model. Predicted vs. 
experimental values for each chemical were then compared and concordance, 
sensitivity, and specificity values were calculated. For the LMO validation, 
randomly selected 10% of the chemicals were removed from the learning set. 
Then the remaining compounds were used to develop the model. The activity of 
each removed chemical was predicted by the n-10% model. Predicted vs. 
experimental values for the removed chemicals were then compared, and the 
n-10% model's concordance, sensitivity, and specificity were determined. This 
was repeated 10,000 times and the average concordance, sensitivity, and 
specificity values were calculated. 
The results of the LNO, LOO and LMO were expressed by three values; they 
are sensitivity, specificity and concordance. The equations for them are: 
Sensitivity = Correct positive predictions/Total positive predictions; Specificity = 
Correct negative predictions/Total negative perditions; Concordance = Correct 
predictions/Total predictions. 
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For the external validation, ten random sets of 10% of the chemicals in the 
learning set were removed, and the remaining 90% of the compounds were used 
to develop a model. The model was then used to predict the activity of those left 
out, and the average sensitivity, specificity, and concordance values of the 10 
random sets were calculated. In contrast to the LMO, the external validation is 
more independent because it does not use any information from the testing set. 
However, the LMO validation uses information of the testing set to decide the 
cutoff point and the percentage of activity. 
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Model summary 
CHAPTER III 
RESULTS AND DISCUSSION 
Together, three sets of cat-SAR models were derived from the NCTRER 
dataset: M+, M- and non-M. The Rule Optimization process was used to seek the 
best model based on the LOO validation. For M+, M- and non-M models, the best 
model's parameters were 4/0.9/0.85, 3/0.85/0.85 and 3/0.910.9 (Table 1), 
respectively. For the best models, they are not the models with the highest 
concordance value. Actually, the highest concordance value for M+, M- and non-M 
were 0.93, 0.92 and 0.89 respectively, and the parameters for them were 
2/0.8/0.95, 8/0.9/0.85 and 5/0.9/0.95 respectively (Table 1). The reason was that 
the model with the highest concordance value did not satisfy other requirements 
for a best model such as the coverage, the balance between sensitivity and 
specificity or the validation results of LNO or LMO. 
For the M+ best model, 1,849 "important" fragments were created, among 
which 909 were fragments associate with ligands, and 940 were fragments 
associated with non-ligands. For M- model, 2,386 important fragments were used, 
and 1,122 were fragments associated with ligand and 1,264 were non-ligand 
related. For this best model, M+ has 535 fewer important fragments than M-. This 
may be due to the parameter difference or the classification of the marginal 
chemicals. To further study this question, the important fragment number for 
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different parameters and classification of marginal chemicals were extracted 
(Table 2). As shown in Table 2, the classification of marginal chemicals has very 
little effect on the fragment number. When comparing M+ and M- models with the 
same parameters there was a difference of only 65 fragments for 3/0.85/0.85 and 
28 fragments for 4/0.910.85. But if the classification of the marginal chemicals is 
the same, the change of parameters produces a bigger difference on fragment 
number. For instance, 4/0.9/0.85 has 612 fewer fragments than 3/0.85/0.85 for M+ 
and 565 fewer for M-. This shows that the difference in parameters is the main 
reason for the difference of important fragments. When the number rule increases 
from 3 to 4, more fragments will be ruled out. It is the same for the proportion rule. 
When it changes from 0.85/0.85 to 0.910.85, the number of qualified fragments will 
decrease. Our experimental data reflect this rule. 
In order to investigate the performance of the M+ and M- models on marginal 
chemicals, the predictions of the eight marginal chemicals by the two sets were 
analyzed. Table 3 shows the prediction of the eight marginal chemicals. For the 
M+ model, three of them were correctly predicted as ligand, three were incorrectly 
predicted as non-ligand, and two were unpredictable. For M- model, five of them 
were correctly predicted as non-ligands, two of them were incorrectly predicted as 
ligands, and one was unpredicted (Table 3). The M- model made more correct 
predictions on marginal chemicals than M+ model. However, we can not conclude 
which model is better because neither this difference because neither the 
difference nor the sample size was big enough to make the conclusion. 
LOO validation 
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LOa validation was performed before LNO and LMO validation because the 
best models were selected based on LOa validation. For the best model of M+, 
sensitivity, specificity and concordance values were 0.91, 0.74 and 0.85, 
respectively (Table 4). For M-, the sensitivity, specificity and concordance values 
were 0.90, 0.81 and 0.86, respectively. For non-M learning set, the sensitivity, 
specificity and concordance values were 0.92, 0.76 and 0.86, respectively. 
Comparing the LOa validation results of the best model of the three sets (M+, M-
and non-M), the sensitivity and concordance values were very similar. This shows 
that the marginal chemicals did not greatly affect the performance of the model. 
Therefore, for the remainder of this study, we concentrated on the models from 
the M+ and M- . 
LNO validation 
After the best models were selected based on LOa, LNO validations were 
carried out using the parameters from the best models. Both M+ and M- models 
produced the same concordance value of 0.92 (Table 4). The sensitivity and 
specificity values for the M+ were 0.96 and 0.84, while for the M- they were 0.97 
and 0.86. For the LNO, the performances of the best model from the two sets 
were very close to each other. LNO validation is also called self-fit validation. The 
characteristic of this kind of validation is that the model is developed from the 
whole learning set, and that model is used to predict the activity of each 
compound in the learning set. 
LMO validation 
The LMO validation yields a concordance value of 0.84 for both M+ and M-
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models. The sensitivity values were 0.90 and 0.89, and specificity 0.75 and 0.77 
for M+ and M-, respectively (Table 4). The validation results of M+ and M- were very 
close to each other. LMO is also a cross-validation. The vital aspect of this 
validation is that more than one chemical was taken out every time from the 
testing set. The selection of testing set was random. In this study, the process was 
repeated for 10,000 times. 
In summary the LNO, LOO and LMO are all internal validations. Comparing 
the three values (sensitivity, specificity and concordance) of LNO, LOO and LMO, 
all the values are in the same order: LNO > LOO > LMO. This trend is reasonable 
because an increasing number of chemicals were removed from the learning set 
from LNO to LMO validation. LNO did not have any chemical removed, LOO had 
one removed each time, and LMO has 10% of the total chemicals removed each 
time. With more chemicals removed, less information is available to develop a 
model, and the difficulty of making a correct prediction increases. Therefore, it is 
reasonable that the value of the LMO validation was lower than LNO and LOO. If 
the results did not show this trend, for example, the LMO had better value than 
LNO or LOO, this means that a systemic mistake may exist. 
External validation 
Table 4 also shows the results of the external validation analysis. The 
average concordance values for M+ and M- are 0.82 and 0.80; the sensitivity 
values were 0.81 and 0.90, and the specificity values were 0.83 and 0.69. The 
concordance values were lower than the LMO validation concordance values. 
According to the external validation, the M+ model is better than M- because it is 
19 
more balanced and has a higher concordance value. For the external validation, 
the testing set is more independent from the training set compared to LMO. 
Therefore the results are more reliable. The values of sensitivity, specificity and 
concordance of the external validation indicate that the NCTRER cat-SAR models 
can identify the ER ligands. 
The relationship of RBA and the prediction 
To study the relationship of the model's LOa predicted values and the RBA 
values, 232 compounds were divided into five groups according to their RBA 
values. The range of the five groups was defined by the NCTRER database [26] 
(Table 5). The slight binders (what we called marginal compounds) group 
(O<RBA<1 E-5) had the lowest percentage of correct predictions with three out of 
eight predictions being correct, which was followed by the non-ligand group in 
which 80% had been predicted correctly. This was a relatively lower percentage of 
correct predictions, especially when compared to the ligand compounds, which is 
over 90%. The weak, medium and strong ligand groups had similar percentages 
of correct predictions with values of 94, 92, and 93%, respectively. To explore the 
cause of this discrepancy, the structure of the compounds incorrectly predicted in 
the lower percentage groups were investigated. There were 19 incorrectly 
predicted compounds in the non-ligand group, and all of them had. an aromatic 
ring and 11 (or 57%) of them contained a phenolic ring. For the slight binder, or 
marginal group, all four compounds predicted incorrectly had aromatic rings and 
none of them had a phenolic ring. As shown previously, the aromatic or phenolic 
ring is an important biophore for estrogenicity and makes them very similar to 
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ligand compounds that actively bind to the ER [23]. If a compound has an 
aromatic or phenolic ring but is not estrogenic, this makes it more likely to be 
incorrectly predicted as a ligand compound. Based on this analysis, it can also be 
concluded that aromatic ring or phenolic ring are not sufficient to determine 
estrogenicity because the non-ligands can also have them. There should be other 
structures that contribute to the binding activity. On the other hand, this also 
shows the predictions of our cat-SAR expert system were based on the structure 
of the chemicals. This should be studied further in the future. 
The relationship of different chemical classes and model prediction 
To further study the relationship between prediction accuracy and the 
chemical categories, the chemicals were sorted by their chemical categories 
according to the NCTRER database classification. The uneven distribution of 
correct predictions was found among different chemical categories for M+ and M-. 
Table 6 shows the result for M+ and M-, where M- had similar results as M+. The 
order for percentage of correct predictions is: biphenyls < diphenylmethane < 
phytoestrogen < phenols < DES < steroids. According to the results, the biphenyls 
group had the lowest percentage of correct predictions, and the steroid group had 
the highest. One reason for the difference in correct predictions may be that the 
sample size for biphenyls is too small. The group only has 12 chemicals in total, 
and one is not predicted. Among the 11 predicted chemicals, four of them were 
incorrectly predicted, and seven of them were correctly predicted. The small 
sample size makes the results easier to be skewed. For other groups, the sample 
size is much larger than the biphenyls. Another possible explanation for this 
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group's low percentage of correct predictions is that the non-ligand chemicals in 
this group all have aromatic ring. For biphenyls, there are three aromatic 
non-ligands out of 12, and all of them are incorrectly predicted. But the steroids, 
which have a high percentage of correct predictions, do not have any aromatic 
non-ligands. Actually the non-ligand aromatic chemicals decreased the 
performance of the model because they have structural alerts similar to ligands 
for the ER. This may lead the model to predict them as ligands. This agrees with 
what was discovered by RBA classification on aromatic non-ligand chemicals. 
Furthermore, according to the structure of biphenyls, they do not have a 
hydrophobic center. This may also contribute to its low performance because 
hydrophobic center is one of the important structures related to ER binding. 
According to our investigation, all the good ER binders have an ideal hydrophobiC 
center. The ideal hydrophobiC center means the proper size with enough 
hydrophobicity. Therefore, the hydrophobicity can also be used to make a 
prediction on binding activity. Comparison of compounds in the biphenyl group to 
those in the diphenylmethane group demonstrates that they all have two aromatic 
rings. The difference is that the diphenylmethane have a hydrophobic center, but 
biphenyls do not. Diphenylmethanes also have non-ligand chemicals with 
aromatic rings. There were nine such chemicals out of 28 chemicals compared to 
biphenyls, which had three out of 12, and six of them were incorrectly predicted. 
Although diphenylmethane compounds also have non-ligand chemicals with 
aromatic ring, it has a higher percentage of correct prediction than biphenyls. This 
is due to its hydrophobiC center which helped the cat-SAR expert system make a 
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correct prediction on the ER ligands. The uneven performance on different 
chemical classes shows that its prediction is based on the structure analysis, and 
important fragments play a vital role in deciding a chemical's activity. It also 
reminds us that having a bigger sample size and similar number of chemicals of 
different chemical classes may improve the performance of the models. 
Furthermore, making the application domain' more specific to a chemical class (Le. 
biphenyls or steroids) may be a better way to improve the model's performance. 
Moreover when these models are used to assess the ligand binding potential for a 
new or untested chemical, it is likely that chemical class and the compound's true 
potency will affect the reliability of the prediction. 
Examples of cat-SAR predictions 
In order to investigate model prediction for compounds, four chemicals of 
different activity were chosen to demonstrate the process. They were 
17~-estradiol, coumestrol, BPA and progesterone whose RBA values were 100, 
0.9, 0.008 and 0, respectively. They are representatives for the strong, medium 
and weak ligands, and the non-ligand categories. 
As demonstrated by the activity and fragment information of 17~-estradiol, it 
was correctly predicted as a ligand compound by M+ and M- (Table 7). Figure 1 
shows the structure of 17~-estradiol and some of the fragments created by two 
sets. In order to perform the analysis, the fragments were divided into three 
sections: section 1 specifically covered the 3-0H group and the affiliated aromatic 
ring A, and section 2 covered the interior Band C rings, and section 3 specifically 
covered the 17-0H group and the affiliated ring D. 
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Fragments from section 1 identify the aromatic ring A and the affiliated 3-0H 
group, which have been identified as two of the most important structural alerts for 
17f3-estradiol [29]. It contributes about 1.5kcal/mol to the total binding energy, 
which is 12kcallmol [30]. If the aromatic ring is replaced with other rings, the 
binding affinity will decrease dramatically. For example, if 17f3-estradiol's aromatic 
ring is replaced with cyclohexane, it becomes 3a-androstanediol (Table 8), and its 
RBA value decreases to 0.002 [31]. In fact, 3a-androstanediol cannot be 
predicted by either of our models. Due to its lack of an aromatic ring, its fragments 
could not be found in the important fragments list of either model. In our study, all 
the fragments of 17f3-estradiol contain part of the aromatic ring. All of this 
information indicates that the model identified this structure and used it to make a 
prediction on ligands or non-ligands. 
To further study the effects of the aromatic ring on model predictions, the 
non-aromatic chemicals were taken out to study independently. Among 232 
compounds, there are 28 compounds that do not have an aromatic ring. For 28 
non-aromatic compounds, five of them are ligands, and 23 are non-ligands. Both 
models correctly predicted all 23 non-ligands, but for the five non-aromatic ligands, 
three were incorrectly predicted, and two were not predicted in both models. Thus, 
there were no correct predictions for the five non-aromatic ligands. This again 
suggests that the aromatic ring is an important structure for ER binding, and the 
model expert system uses it to make a correct prediction for ER ligands. 
Section 1 also includes the structure 3-0H. The 3-0H group contributes 
approximately 1.9kcal/mol of binding energy as a hydrogen bond donor [30]. It 
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forms a hydrogen bond with the Glu 353, Arg 394, and a water molecule [31,32]. 
When the 3-0H group is removed, the RBA value drops significantly when 
comparing similar compounds (e.g. 3-deoxy-estradiol). In the fragment list of 
17~-estradiol, we found four fragments that contained the 3-0H group, and all of 
them were mostly found in the fragment list of ligands. This shows that our models 
can identify the 3-0H group as a structural alert for ER ligands. 
The fragments from section 2 are derived from the hydrophobic center for 
17~-estradiol [30]. The ligand binding domain (LBO) of ER is a hydrophobic 
pocket, which creates a favorable environment for binding ligands that possess a 
hydrophobic center [33]. Another important aspect of section 2 in relation to 
17~-estrodiol is that it creates a favorable distance between the 3-0H and 17 -OH 
group. The distance between these two hydroxyl groups is do-c. It is a factor that 
affects the binding affinity of a ligand [31]. Either too large or too small do-o is not 
favorable for ER binding, and a certain range of do-o can make the binding more 
stable. For example, the do-o for 17~-estrodiol is 11.0 A, which allows the 3-0H 
and 17-0H to appropriately align with the ER binding pocket and form hydrogen 
bonds, which creates a much stronger interaction between the receptor and the 
ligand, thus increasing the binding affinity. The compounds that do not have a 
steroidal backbone usually have very low RBA value, even though they have an 
aromatic ring or a -OH group, such as the phenols, and biphenyls. The reason for 
this is that the steroidal backbone offers the favorable conformation for ligand 
binding [31]. This explains why the average RBA value of steroid compounds is 
higher than biphenyls because the steroids have the hydrophobic center and the 
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do-o value is similar to the natural estrogen. 
In the fragment list, there are 253 fragments that cover this section. Among 
the three sections, this section has the largest number of fragments because this 
section also includes parts of the aromatic ring. There is no important fragment 
that does not have any part of the aromatic ring. Therefore, we can conclude that 
only the hydrophobic fragments are not enough for receptor binding. It has to be 
coupled with an aromatic ring to form a ligand. This may explain why fragments of 
section 2 all have some part of the aromatic ring. 
The fragments from section 3 identify the 17 -OH group, which contributes 
about O.6kcal/mol as a hydrogen bond acceptor [29]. The 17 -OH group can form 
an H-bond with His 524 [31]. If the 17 -Ot-{ group was removed, the RBA would 
decrease. For example, the 17-deoxy-estradiol has a RBA value of 14.1 which is 
seven times lower than 17f3-estradiol. Although 17 -deoxy-estradiol does not have 
the 17-0H group, it was correctly predicted as a ligand in our model (Table 8). 
This suggests that 17 -OH is important, but it is not imperative for activity. The M+ 
and M- models have the same fragment for section 3, which is a 17 -OH group 
affiliated with a four ring skeleton, and it is the only fragment found in this section. 
These findings demonstrate that 17 -OH is a structural alert for ER ligands, but by 
itself is not enough to greatly affect ligand's binding ability to the ER. In fact, it 
seems that 17 -OH needs to be combined with hydrophobic fragments and 
aromatic fragments to construct a complete ligand. Therefore, the 17 -OH is not a 
necessary structure for the ER ligand, but it is a structure that can increase the 
binding affinity of a compound to the ER. 
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Coumestrol is a phytoestrogen and another ER ligand in the learning set. 
Coumestrol has three aromatic rings, two at the ends of the compound and one in 
the middle. The chemical shape of coumestrol orients its two hydroxyl groups in 
the same position as the two hydroxyl groups in 17p-estradiol, allowing it to mimic 
the structure confirmation of 17p-estradiol. However, The RBA value for 
coumestrol is 0.90, which is about 100 times lower than 17p-estradiol. It was 
predicted as a ligand compound by M+ and M-. The M+ and M- models created 
eight and ten fragments in total, respectively, and all of them described the phenol 
ring. Five representative fragments from both sets are shown in Figure 2. From 
the fragments of coumestrol, we found that all of the important fragments describe 
the aromatic rings, either ring A or D. Comparison of coumestrol to 17p-estradiol 
suggests that they have many similarities. They both have four rings and two -OH 
groups at the A ring and D ring, which may explain why coumestrol binds to the 
ER. However, coumestrol's RBA value is much lower than 17p-estradiol, which 
means coumestrol is a relatively weaker binder compared to 17p-estradiol. This 
may due to the fact that coumestrol's hydrophobic center is weaker than 
17p-estradiol because it has three oxygen atoms, which makes it more hydrophilic 
[34]. For the important fragments of coumestrol, none can represent the 
hydrophobic center. This study shows the important fragments created by 
cat-SAR were related to the ER binding activity. 
Bisphenol A is used to make polycarbonate plastiC and epoxy resins, along 
with other applications. There is concern that the wide daily use of it may be 
related to some potential negative health effects [35-36]. It was predicted as a 
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ligand by both M+ and M- models. The important fragments of BPA are shown in 
Figure 3. These fragments describe three parts: the -OH group, the aromatic ring 
and the bridge hydrocarbons. All of the fragments are related to the activity of BPA. 
The bridge hydrocarbons act in a similar manner as the fragments from section 2 
for 17j3-estrodial by forming a hydrophobic center. However, this center in BPA is 
much smaller than in 17j3-estradiol. Therefore, the do-o of BPA is shorter than 
17j3-estradiol, and may explain why BPA's RBA value is much smaller than 
17j3-estradiol. 
Progesterone, a vital hormone for pregnancy, is a non-ligand in both M+ and 
M- learning sets and was correctly predicted by both models. In the M+ model, it 
had 285 fragments in total, and 52 of them had an oxygen atom. All of the oxygen 
atoms in those fragments were linked by a double bond, which prevents the 
compound from forming a hydrogen bond with the ER. Also, this compound has 
no aromatic rings. The lack of these structural features contributes to 
progesterone's inactivity. Figure 4 shows some of the representative fragments of 
progesterone and represents the differences in important fragments associated 
with ligands and non-ligands. 
From the above examples, we get a better understanding of what type of 
fragments are most likely to construct a ligand or non-ligand compound. Therefore, 
the cat-SAR expert system can not only make predictions for unknown 
compounds, but also assist in the analysis of identifying the binding mechanism 
and, therefore, potentially help in designing new compounds with specific 
characteristics. 
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CHAPTER IV 
SUMMARY AND CONCLUSION 
Overall, the present study demonstrated the utility of SAR modeling for 
xenoestrogens screening and the ER binding mechanism study. The cat-SAR 
expert system is a qualitative SAR, and its predictions are based on the activity of 
the fragments derived from each chemical, and the predicted activity of each 
compound is calculated by the frequency with which each fragment is found in 
either ligands or non-ligands. Therefore, the learning set always consists of a 
certain number of ligand and non-ligand chemicals as the NCTRER database 
used in this study. 
NCTRER is a unique database for analyzing xenoestrogens and ER binding, 
since it contains a diverse set of chemicals with a wide range of binding affinities. 
The database includes 232 compounds, of which 131 are ligands, 93 are 
non-ligands and 8 are marginally binding chemicals. In total, 37 descriptors were 
listed for each chemical, including their RBA value, their chemical class, and the 
number of aromatic rings each chemical possesses, among others. In this study 
these descriptors were used to understand how they affect ligand binding to the 
ER. For example, the relationship of why different chemical classes bind to the ER 
with varying degrees of RBA was analyzed. Although the role of just a few 
descriptors was investigated in this study, it is believed that the cat-SAR expert 
system will be very useful in investigating the remainder of the descriptors 
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found in the NCTRER database. Four different validation methods were used in 
this investigation: LNO, LOO, LMO and external validation. The sensitivity, 
specificity and concordance value were calculated for each of the validations. The 
concordance values were all above 80%, meaning the cat-SAR methodology is 
capable of making correct predictions for ER ligands. 
The overall performance for the model was very good, but a discrepancy was 
identified in the overall correct predictive rate among six different chemical 
classes, including biphenyls, diphenylmethane, phytoestrogen, phenols, DES and 
steroids. For example, the percentage of correct predictions for biphenyls was 
only 63%, but it was 93% for steroids, according to the M+ model. This indicates 
that the closer a chemical's structure to the natural estrogen the higer possibility 
of it being predicted correctly by the model. This also suggests that the models 
have different predictive performances on different chemical classes (Le., 
chemical structure or potency). Therefore, when these models are used to assess 
the ligand binding potential for a new or untested chemical, it is likely that 
chemical class and the compounds true potency will affect the reliability of the 
prediction. 
Important fragments were identified by the cat-SAR expert system for each 
chemical. The important fragments for the ligands covered most of the existing 
biophores for ER binding such as the aromatic ring, 3-0H group, 17 -OH group 
and the hydrophobic center. But most of non-ligands do not contain the fragments 
that were known as structures alerts related to ER binding. This shows the 
cat-SAR expert system is mechanistically sound and can be used to carry out 
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mechanism analysis in the future. Meanwhile, there are some fragments that can 
not be explained by the exiting structural alerts; this offers the possibility of 
discovering new biophores. 
This study identified some important fragments for ER binding. However, it 
is far from completed because we found some chemicals that do not have 
structure alerts, but are ligands. For instance, we found that there are 25 
chemicals with the phenolic ring but were non-ligands, and 14 of them were 
correctly predicted by the M+ model. This demonstrates that there should be 
other structures that define an estrogeniC chemical besides the phenolic ring. 
Even when considering the phenolic ring, the location of the -OH group critically 
affects the activity of the chemicals. These are examples of chemical structural 
analysis that could be part of our future studies. 
In conclusion, the NCTRER cat-SAR ER binding model is a reliable model for 
xenoestrogen identification. The cat-SAR expert system identified important 
fragments for ER binding that help explain why certain xenoestrogens bind to the 
ER better than others. Therefore, this model can be used to do xenoestrogen 
screening and potentially identify how well compounds will bind to the ER, strictly 
based on their chemical structure. Furthermore, future studies may lead to the 
discovery of other possible structural alerts for ER binding or estrogenicity. 
Understanding these structural characteristics may lead to a better mechanism for 
dealing with the carcinogenic and anti-carcinogenic properties associated with 
these xenoestrogens. Making use of this model, or combining it with other models, 
could explore this question in a meaningful direction. 
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TABLES 
Table 1. M+, M- and non-M Model comparison 
Parameters Sen1 
Best Model 4/0.9/0.85 0.91 
M+ 
Highest Ocp 2/0.8/0.95 0.93 
Best Model 3/0.85/0.85 0.90 
M-
Highest Ocp 8/0.910.85 0.92 
Non- Best Model 3/0.9/0.9 0.89 
M Highest Ocp 5/0.9/0.95 0.96 
Note: 1. Sen is the abbreviation for Sensitivity. 
2. Spe is the abbreviation for Specificity. 
Spe2 OCp3 Cutoff Coverage 
0.74 0.85 0.90 0.86 
0.86 0.91 0.83 0.97 
0.81 0.86 0.86 0.91 
0.91 0.92 0.92 0.61 
0.76 0.86 0.89 0.90 
0.77 0.89 0.90 0.84 
3. Ocp is the abbreviation for observed correction prediction, and equals to concordance 
value. 
The Sensitivity, Specificity and Concordance value is based on the LOO 
validation. 
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TABLES 
Table 2. Fragments table 
Total Ligand Non-ligand 
Model Parameter 
Fragments Fragments Fragments 
M+ 3/0.85/0.85 2461 1214 1247 
M- 3/0.85/0.85 2386 1122 1264 
M+ 4/0.901.85 1849 909 940 
M- 4/0.910.85 1821 863 958 
This table compares the number of fragments of the different classification of 
marginal chemicals and parameters. Both the classification of marginal chemicals 
and the parameter affect the number of fragments. M+ model has more fragments 
than M- with the same parameter. For the same classification of marginal 
chemicals, the fragments increase with the values of parameter increases. The 
changing of parameter has more effects on fragments number than the 
classification of the marginal chemicals. 
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TABLES 
Table 3. Marginal binding chemicals prediction. 
CAS M+ 
117-81-7 incorrect 
2132-70-9 correct 
32598-13-3 unpredictable 
3424-82-6 correct 
53-19-0 incorrect 
6554-98-9 correct 
85-68-7 incorrect 
90-00-6 unpredictable 
M-
correct 
correct 
incorrect 
unpredictable 
correct 
incorrect 
correct 
correct 
Eight marginal chemicals and their predicted results from M+ and M- were 
listed. 
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TABLES 
Table 4. Validation summary for cat-SAR ER binding models 
Validation Model Sensitivity 1 Specificity2 Concordance3 
LNO M+ 0.96(121/126) 0.84(58/69) o .92( 179/195) 
M- 0.97(121/125)1 0.86(73/85) 0.92(194/210) 
LOO M+ 0.91 (115/127) 0.74(54/73) 0.85(169/200) 
M- 0.90(111/124) 0.81(70/87) 0.86(181/211) 
non-M 0.92(113/123) 0.76(59/78) 0.86(172/201 ) 
LMO M+ 0.90(10.0/11.1 ) 0.75(5.0/6.7) 0.84(15.0/17.8) 
M- 0.89(10.5/11.8) 0.77(6.3/8.2) 0.84(16.8/20.0) 
External M+ 0.81(107/132) 0.83(63/76) 0.82(170/208) 
validation M- 0.90(106/120) 0.69(64/92) 0.80(170/212) 
Notes: 1. Number of correct positive predictions I total number of positives; 
2. Number of correct negative predictions I total number of negatives; 
3. Observed Correct Predictions: number of correct predictions I total number of predictions 
The table shows the validation results for LNO, LOO, LMO and external 
validation for M+ and M - models, and also the LOO for the Non-M model. 
Sensitivity, specificity and concordance values were calculated and listed in the 
table. For LMO, the number of chemicals in parentheSiS is the average of 10% 
removed chemicals. 
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TABLES 
Table 5. Distribution of incorrect predictions for M+ model 
Total Unpredictable 
M+ 
Compounds group compounds compounds Number of Percentage 
number number correct of correct 
predictions predictions 
Non-ligand 93 0 74 80% (RBA=O) 
Slight binder 8 2 3 50% (0<RBA::;1 E-5) 
weak Ligand 61 9 49 94% (1 E-5<RBA::;0.01) 
medium Ligand 41 1 37 92% (0.01 <RBA::;1) 
strong Ligand 29 0 27 93% (RBA>1) 
The compounds were divided into five groups according to their RBA value. 
The number of correct predictions and percentage of correct perditions were 
calculated. 
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TABLES 
Table 6. Prediction on different chemical classes 
Ligands Number of Number of Correct 
Categories Compound 1 Prediction 
Biphenyls 11 7 
Diphenymethane 28 21 
Phytoestrogen 44 35 
Phenols 27 24 
DES 22 20 
Steroids 29 27 
Percentage of 
correct Predictions 
63% 
75% 
80% 
89% 
91% 
93% 
Notes: 1. Number of compound does not include the unpredicted compounds. 
This table shows the performance of cat-SAR ER binding model of M+ on 
different chemical classes. The number and percentage of correct predictions 
were calculated. 
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TABLES 
Table 7. Activity and fragment information for 17f3-estradiol 
Predicted 
Experimental Fragments 
Model percentage of 
activity number 
activity 
M+ (4/0.9/0.85) ligand 97% 258 
M- (3/0.85/0.85) ligand 95% 281 
The activity and fragment information for 17f3-estradiol in both models. 
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TABLES 
Table 8. Structure and activity comparison for steroids 
Structure RBA Predicted activity 
# 0.002 Unpredictable 
oY5H HO 3a ·androstanediol roB" HO .0 0.5 Ligand I~ 17(3-estradiol Q 
3·Deoxy·estradiol 
RBA=100 m±> 14.1 Ligand HO Q 
17-Deoxy -estradiol 
The effects of 3-0H, 17 -OH group and aromatic ring on RBA value were 
shown. The predictions of these three chemicals were also listed. The aromatic 
ring has the biggest effect on activity then is the 3-0H group, then the 17-0H 
group. 
39 
FIGURES 
Section I 
4321 
21122 
HO 
0.96 XO 
Section 2 
if 4044 " 17/17 1.00 
2228 d 24/25 0.96 
4076 
20/21 y)J-0.95 I I 
Section 3 
4018 ~x BIB 
1.00 
1661 
47/55 
0.86 
2208 
25/28 
0.89 
2227 
25/27 
0.9J 
2242 
J4/38 
0.90 
4018 
BIB 
1.00 
OH Key: 
Frag Number 
ActivelTotal 
Pr(act) 
Open ended bonds 
and unfiled valences 
can be filed with 
any atom. 
M-
HO 
~ 
j() 
yC' 
~x 
''I 
I 
I 
Figure 1. Important fragments of 17p-estradiol. All the important fragments 
can be divided into three sections. Each section represents certain part of the 
chemical. 
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Figure 2. Important fragments of coumestrol. All the important fragments 
contains part of an aromatic ring and a -OH group. 
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Section A 
1661 
47/55 
M" 
0.86 XO 
Section B 
3849 
34/36 
0.94 
3731 
34/36 
0.94 
3782 
32/34 
0.94 
4358 
3/3 
1.00 
Figure 3 Fragments of bisphenol A 
Figure 3. Important fragments of bisphenol A. The fragments were divided 
into two parts: section A and section B. Section A is the phenolic ring, and section 
B is the aromatic ring and the hydrophobic center. 
42 
FIGURES 
Key: 
Frag Number 
ActivelT otal 
Pr(act) 
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and unfiled valences 
can be filed with 
any atom. 
0 
M+ M-
11221 o~ 11213 o~ 0/5 0/4 0 0 
10969 ;:l 11015 JJ 0/5 0/4 0 0 
10955 f) 10960 b IIR 1/9 0.125 0 
279R ~ 2729 b 0/8 0/8 0 0 
2779 6 11642 6 0/8 0/3 0 0 
Figure 4 Fragments of progesterone 
Figure 4. Important fragments of progesterone. The percentage of activity of 
the fragments was "0". No fragment that related to any biophores for ER binding 
was found in the fragment list. 
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APPENDIX 
List of Abbreviations 
NCTRER 
RBA 
ER 
MultiCASE 
QSAR 
SAR 
Cat-SAR 
CoM FA 
GPCR 
ED 
PCB 
DDT 
BPA 
LNO 
LOO 
LMO 
National Center for Toxicological Research Estrogen Receptor 
Relative Binding Affinity 
Estrogen Receptor 
Multiple Computer Automated Statistical Evaluation Expert 
System 
Quantitative Structure Activity Relationship 
Structure Activity Relationship 
Categorical- Structure Activity Relationship 
Comparative Molecular Field Analysis 
G Protein-Coupled Receptor 
Endocrine Disruptor 
Polychlorinated Biphenyls 
Dichlorodiphenyltrichloroethane 
BisphenolA 
Leave-none-out 
Leave-one-out 
Leave-many-out 
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